Successful Desensitization to Imiglucerase of an Adult Patient Diagnosed with Type I Gaucher Disease

Publisher： Karger

E-ISSN： 1423-0097|160|2|215-217

ISSN： 1018-2438

Source： International Archives of Allergy and Immunology, Vol.160, Iss.2, 2012-09, pp. : 215-217

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Safety and efficacy results of switch from imiglucerase to velaglucerase alfa treatment in patients with type 1 Gaucher disease

By  

AMERICAN JOURNAL OF HEMATOLOGY, Vol. 90, Iss. 7, 2015-07 ,pp. : 592-597

John Wiley & Sons Inc

Access to resources Recommend Favorite

Therapeutic Potential of Resveratrol in Type I Gaucher Disease

By  

PHYTOTHERAPY RESEARCH, Vol. 29, Iss. 6, 2015-06 ,pp. : 835-839

John Wiley & Sons Inc

Access to resources Recommend Favorite

Vertebral fractures in Gaucher disease type I: data from the French “Observatoire” on Gaucher disease (FROG)

By Javier R.-M.   Hachulla E.   Rose C.   Gressin V.   Chérin P.   Noël E.   Roux-Serratrice C.   Dobbelaere D.   Hartmann A.   Jaussaud R.   Clerson P.   Grosbois B.   Roux C.  

Osteoporosis International, Vol. 22, Iss. 4, 2011-04 ,pp. : 1255-1261

Springer Publishing Company

Access to resources Recommend Favorite

Pyrazinamide-Induced Anaphylaxis: Diagnosed by Skin Test and Successful Desensitization

By  

International Archives of Allergy and Immunology, Vol. 157, Iss. 2, 2011-10 ,pp. : 209-212

Karger

Access to resources Recommend Favorite

Seven‐year safety and efficacy with velaglucerase alfa for treatment‐naïve adult patients with type 1 Gaucher disease

By  

AMERICAN JOURNAL OF HEMATOLOGY, Vol. 90, Iss. 7, 2015-07 ,pp. : 577-583

John Wiley & Sons Inc

Access to resources Recommend Favorite